fig5
![Activation of the cGMP/protein kinase G system in breast cancer by the dopamine receptor-1](https://image.oaes.cc/aad43cfc-e6c6-4871-9005-905c6b18a9b2/3266.fig.5.jpg)
Figure 5. Suppression of MDA-MB-231 cell viability by DA and three dopamine receptor-1 (D1R)-selective agonists. SKF: SKF38393; A6: A68930; Fen: Fenoldopam. Cabergoline (Cab), a D2R agonist, has no effects. Redrawn and modified[2]
Figure 5. Suppression of MDA-MB-231 cell viability by DA and three dopamine receptor-1 (D1R)-selective agonists. SKF: SKF38393; A6: A68930; Fen: Fenoldopam. Cabergoline (Cab), a D2R agonist, has no effects. Redrawn and modified[2]
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/